Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $4.2 million.

  • Ocular Therapeutix's Accounts Payables fell 52.68% to $4.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.2 million, marking a year-over-year decrease of 52.68%. This contributed to the annual value of $4.2 million for FY2025, which is 52.68% down from last year.
  • According to the latest figures from Q4 2025, Ocular Therapeutix's Accounts Payables is $4.2 million, which was down 52.68% from $6.3 million recorded in Q3 2025.
  • Ocular Therapeutix's 5-year Accounts Payables high stood at $6.5 million for Q1 2024, and its period low was $3.4 million during Q1 2022.
  • For the 5-year period, Ocular Therapeutix's Accounts Payables averaged around $4.6 million, with its median value being $4.2 million (2021).
  • In the last 5 years, Ocular Therapeutix's Accounts Payables surged by 6950.9% in 2021 and then crashed by 2831.24% in 2025.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Accounts Payables stood at $4.6 million in 2021, then increased by 11.56% to $5.1 million in 2022, then decreased by 14.33% to $4.4 million in 2023, then dropped by 4.85% to $4.2 million in 2024, then decreased by 0.53% to $4.2 million in 2025.
  • Its Accounts Payables stands at $4.2 million for Q4 2025, versus $6.3 million for Q3 2025 and $5.9 million for Q2 2025.